Heron Therapeuti (HRTX) Peer Comparison

$0.32

$0.00 (1.57%)

As on 03-Sep-2026 14:38EDT

Market cap

$62 Mln

Revenue (TTM)

$151 Mln

P/E Ratio

--

P/B Ratio

10.9

Div. Yield

0 %

Edit

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	62	16,765	16,261	13,492	11,994
Revenue ($ Mln)	151	2,782	1,054	2,436	670
Net Profit ($ Mln)	-34.05	491.50	755.85	860.62	-319.95
Net Margin (%)	-22.52	17.67	71.69	35.33	-47.79
RoE (%)	-320.60	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	10.94	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	151.18	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	45.24	1,982.07	103.47	85.67	19.14
Gross Profit	113.56	760.62	588.53	2,236.43	829.45
Operating Expenses	116.80	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-10.86	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-34.05	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-34.05	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	6.91	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	153.21	187.89	384.48	288.55	1,362.63
Current Liabilities	92.15	1,435.43	464.70	361.93	283.35
Total Liabilities	255.88	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	22.42	1,006.90	895.24	1,243.41	440.60
Current Assets	229.85	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	255.88	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	148.35	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-27.59	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	16.01	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	14.43	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-13.50	53.56	-30.01	32.82	-0.17
ROE (%)	-320.60	110.09	163.18	42.98	-71.14
ROA (%)	-7.00	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-16.31	21.13	5.73	31.04	-0.77
Net Margin (%)	-22.52	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	0.99	24.67	114.85	9.23	12.22
EBIT Growth (%)	-640.91	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-3,557.25	17.50	378.76	42.89	-115.58
EPS Growth (%)	-3,050.10	26.84	353.27	50.42	-73.87
Book Value Growth (%)	120.51	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-10.73	36.06	-59.76	15.79	-2,869.63
Price / Book Value	15.12	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-17.38	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.03	0.00	0.05	0.00	0.09
Current Ratio	2.49	0.73	2.99	3.46	5.90
Quick Ratio	1.51	0.73	2.32	3.38	5.90
Interest Coverage	-7.73	--	1.62	--	-1.72

Operating Efficiency Ratios

	Heron Therapeuti (HRTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	59.25	15.88	21.25	13.74	1.28
Asset Turnover	0.31	0.89	0.37	0.83	0.34
Receivable days	198.62	50.42	85.52	43.48	1.50
Inventory Days	644.45	--	1,056.70	96.17	--
Payable days	91.44	6.26	331.01	147.97	221.81
Cash Conversion Cycle	751.62	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly